The expanded recall includes:
The recall of these drugs had previously been issued at the wholesale level, but is now being expanded to the retail level. ETHEX is taking this action as a precautionary measure, because the products may have been manufactured under conditions that did not sufficiently comply with the Food & Drug Administration’s current Good Manufacturing Practice (cGMP) regulations.
- Morphine Sulfate Extended-Release Tablets 15mg, 30mg & 60mg (All Strengths)
- Morphine Sulfate Immediate-Release Tablets 15mg & 30 mg (All Strengths)
- Dextroamphetamine Sulfate Tablets 5mg & 10mg (All Strengths)
- Isosorbide Mononitrate Extended-Release Tablets 30mg, 60mg & 120mg (All Strengths)
- Propafenone HCl Tablets 150mg, 225mg & 300 mg (All Strengths)